FACTORS ASSOCIATED WITH SYNCHRONOUS METASTATIC PRESENTATION AND 24-MONTH PROGRESSION-FREE SURVIVAL IN COLORECTAL CANCER

Authors

  • Diana-Ioana PANAITE Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
  • Simona-Ruxandra VOLOVAT Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
  • Iolanda Georgiana AUGUSTIN Carol Davila University of Medicine and Pharmacy Bucharest, Romania
  • Madalina OSTAFE Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
  • C. C. VOLOVAT Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
  • Maria-Luiza BAEAN Carol Davila University of Medicine and Pharmacy Bucharest, Romania
  • Ingrid-Andrada VASILACHE Ștefan cel Mare University, Suceava, Romania
  • C. VOLOVAT Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania

DOI:

https://doi.org/10.22551/MSJ.2026.03.05

Keywords:

COLORECTAL CANCER; SYNCHRONOUS METASTASES; MAGNETIC RESONANCE IMAGING; EXTRA-MURAL VENOUS INVASION; CIRCUMFERENTIAL RESECTION MARGIN; RISK STRATIFICATION

Abstract

Early identification of patients presenting with synchronous metastatic colorectal cancer (mCRC) is essential for optimizing staging and treatment. This study aimed to identify preoperative MRI-derived tumor characteristics independently associated with synchronous metastatic presentation and to develop an internally validated preoperative clinical–imaging prediction model. Materials and methods: We prospectively enrolled 161 patients with colorectal cancer, including 23 (14.3%) with synchronous metastatic disease. Univariable and multivariable Firth penalized logistic regression identified independent preoperative predictors of metastatic presentation. Model performance was assessed using the area under the receiver operating characteristic curve (ROC-AUC) and internally validated by leave-one-out cross-validation (LOOCV). Secondary analyses evaluated pathological and perioperative characteristics associated with metastatic disease, while progression-free survival (PFS) was estimated using the Kaplan–Meier method. (3) Results: Patients with synchronous mCRC more frequently presented with positive MRI circumferential resection margins (mCRM), MRI-detected extramural venous invasion (mrEMVI), anterior tumor location, and tumors located <4 cm from the anal verge (all p < 0.001). In multivariable analysis, mrEMVI (adjusted OR 16.11, 95% CI 3.09–83.97; p < 0.001) and positive mCRM (adjusted OR 7.56, 95% CI 1.57–36.31; P = 0.012) remained independently associated with synchronous metastatic presentation. The parsimonious preoperative model demonstrated an apparent ROC-AUC of 0.904 and a cross-validated ROC-AUC of 0.846 (95% CI 0.706–0.961), with a Brier score of 0.063. Metastatic patients also exhibited higher rates of positive pathological circumferential resection margins, incomplete total mesorectal excision, perioperative blood transfusion, and extensive nodal involvement. Estimated PFS was 75.0% at 24 months and 41.7% at 36 months. Conclusions: Preoperative mrEMVI and positive mCRM are independent MRI biomarkers of synchronous metastatic colorectal cancer. 

References

1. Ciardiello F, Ciardiello D, Martini G, Napolitano S, Tabernero J, Cervantes A. Clinical management of metastatic colorectal cancer in the era of precision medicine. CA: A Cancer Journal for Clinicians 2022; 72: 372-401.

2. Filip S, Vymetálková V, Petera J, et al. Distant Metastasis in Colorectal Cancer Patients-Do We Have New Predicting Clinicopathological and Molecular Biomarkers? A Comprehensive Review. International Journal of Molecular Sciences 2020; 21(15): 5255.

3. Fan Y, Yang R, Shu Y, et al. Preoperative prediction and localization of synchronous metastases in colon cancer: the role of CECT combined with clinical characteristics. BMC Cancer. 2025; 25(1): 1755.

4. Li Q, Wang G-P, Luo J, Li B, Chen W. Clinicopathological factors associated with synchronous distant metastasis and prognosis of stage T1 colorectal cancer patients. Scientific Reports 2020; 11(1): 8722.

5. Chen P-C, Kao Y-K, Yang P-W, Chen C-H, Chen C-I. Nomogram Development for Predicting Synchronous Lung Metastasis in Patients with T1 Colorectal Cancer: A SEER-Based Analysis. Medicina 2026; 62(3): 431.

6. Schatoff E, Homsi R, Chou J, et al. Risk Factors, Clinical and Molecular Characteristics of de novo Metastatic Early Onset Colorectal Cancer. Journal of Clinical Oncology 2025; 43(16_suppl): 3529-3529.

7. Loroña N, Sankar K, Stern M, Schmit S, Figueiredo J. De novo metastases in patients with primary colorectal cancer: A Surveillance, Epidemiology, and End Results analysis. Cancer Causes & Control 2025; 36: 937-946.

8. Pau S, Eglinton T, Wang A, Fischer J. Pre-operative predictors of completeness of cytoreduction for colorectal peritoneal metastases: a systematic review of radiological, clinicopathological and biomarker-based predictors. European Journal of Surgical Oncology 2025; 51(12): 110537.

9. Aljbri A, You Q, Aljbri A, et al. Diagnostic Performance of Preoperative Imaging-based Radiomics Models for Predicting Liver Metastases in Colorectal Cancer: A Systematic Review and Meta-analysis. Acad Radiol 2026; 33(4): 1378-1396.

10. Brown I, Zammit A, Bettington M, et al. Pathological features associated with metastasis in patients with early invasive (pT1) colorectal carcinoma in colorectal polyps. Histopathology 2023; 83(4): 591-606.

11. Cabana EV, Acosta SEC, Calle C, et al. Clinical-pathologic characteristics in young patients with metastatic colorectal cancer: Experience from a specialized cancer institute in Peru. Journal of Clinical Oncology 2025 43(4_suppl): 279-279.

12. Li S-Y, Yang M, Liu Y-M, Sun M-J, Zhang H-J. Endoscopic and pathological characteristics of de novo colorectal cancer: Retrospective cohort study. World Journal of Gastroenterology 2023; 29: 2836-2849.

13. Akkuş E, Karaoğlan B, Kayaalp M, Turmuş U, Akyol C, Utkan G. Stage‐specific characterization of “early‐onset colorectal cancer”: Localized and synchronous metastatic disease. International Journal of Cancer 2025; 156: 2340-2351.

14. Goh V, Mallett S, Rodriguez-Justo M, et al. Evaluation of prognostic models to improve prediction of metastasis in patients following potentially curative treatment for primary colorectal cancer: the PROSPECT trial. Health Technology Assessment. 2025; 29(8): 1-91.

15. Fournier FR, Motamedi MA, Brown C, et al. Oncologic Outcomes Associated With MRI-detected Extramural Venous Invasion (mrEMVI) in Rectal Cancer. Annals of Surgery 2021; 275: 303-314.

16. Siddiqui MR, Simillis C, Hunter C, et al. A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs. mrEMVI-negative cases. British Journal of Cancer 2017; 116(12): 1513-1519.

17. Zhang Y, Qin X, Luo R, Wang H, Wang H, Luo H-Z. Risk Factors for Synchronous Peritoneal Metastases in Colorectal Cancer: A Systematic Review and Meta-Analysis. Frontiers in Oncology 2022; 12: 885504.

18. Geffen E, Nederend J, Sluckin T, et al. Prognostic significance of MRI-detected extramural venous invasion according to grade and response to neo-adjuvant treatment in locally advanced rectal cancer A national cohort study after radiologic training and reassessment. European Journal of Surgical Oncology 2024; 50(6): 108307.

19. Al-Sukhni E, Al-Sukhni E, Milot L, et al. Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metastases, and Circumferential Resection Margin Involvement in Patients with Rectal Cancer: A Systematic Review and Meta-analysis. Annals of Surgical Oncology 2012; 19: 2212-2223.

20. Meyer J, Wheeler J, Simillis C, Davies J. Comment on: Prognostic importance of circumferential resection margin in the era of evolving surgical and multidisciplinary treatment of rectal cancer: a systematic review and meta-analysis. Surgery 2021; 170(5): 1592-1593.

21. Fernandes MC, Gollub MJ, Brown G. The importance of MRI for rectal cancer evaluation. Surg Oncol 2022; 43: 101739.

22. Yao X, Zhu X, Deng S, et al. MRI-based radiomics for preoperative prediction of recurrence and metastasis in rectal cancer. Abdominal Radiology 2024; 49: 1306-1319.

23. Yanqing, Dongnan, Xu X, Li J, Guan Z. Progress of MRI in predicting the circumferential resection margin of rectal cancer: A narrative review. Asian Journal of Surgery 2024; 47(5): 2122-2131.

24. Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey EL. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 1994; 73(8): 2076-2082.

25. Alexandrescu S, Anastase D, Grigorie R, et al. Influence of the Primary Tumor Location on the Pattern of Synchronous Metastatic Spread in Patients with Stage IV Colorectal Carcinoma, according to the 8th Edition of the AJCC Staging System. Journal of Gastrointestinal and Liver Diseases 2020; 29(4): 561-568.

26. Rumpold H, Niedersüß-Beke D, Heiler C, et al. Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis. BMC Cancer 2020; 20(1): 1149.

Additional Files

Published

2026-09-28

Issue

Section

INTERNAL MEDICINE - PEDIATRICS